Zobrazeno 1 - 5
of 5
pro vyhledávání: '"M Robikhul Ikhsan"'
Autor:
Vitarani Dwi Ananda Ningrum, Ahmad Hamim Sadewa, Zullies Ikawati, Rika Yuliwulandari, M Robikhul Ikhsan, Rohmatul Fajriyah
Publikováno v:
PLoS ONE, Vol 17, Iss 7, p e0271410 (2022)
Interindividual variation is important in the response to metformin as the first-line therapy for type-2 diabetes mellitus (T2DM). Considering that OCT1 and MATE1 transporters determine the metformin pharmacokinetics, this study aimed to investigate
Externí odkaz:
https://doaj.org/article/4b6cf14785084c48b402d5da7eac4600
Publikováno v:
Review of Primary Care Practice and Education (Kajian Praktik dan Pendidikan Layanan Primer). 2:32
Background: The consumption of traditional medicine is very much done in the society including by type 2 diabetes mellitus patients.Purpose: This study is purposed to understand the reasons of type 2 diabetes mellitus patients at the Public Health Ce
Autor:
S Saepudin, Ahmad Hamim Sadewa, M. Robikhul Ikhsan, Vitarani Dwi Ananda Ningrum, Zullies Ikawati
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. 10:294
Objective: This study aimed to determine the metformin plasma steady-state concentration (PSSC) either trough and peak level in Type 2 diabetes mellitus patients with obesity and the impact of SLC22A1 gene organic cation transporter 1 (OCT) rs628031
Autor:
Hemi, Sinorita, Maliyah, Madiyan, R Bowo, Pramono, Luthfan Budi, Purnama, M Robikhul, Ikhsan, A H, Asdie
Publikováno v:
Acta medica Indonesiana. 42(1)
To know the frequencies of insertion/deletion polymorphism in the angiotensin-converting enzyme (ACE) gene among patients with type 2 diabetes and its relationship with metabolic syndrome at Sardjito Hospital Yogyakarta.We examined 69 patients with t
Autor:
Vitarani Dwi Ananda Ningrum, Zullies Ikawati, Ahmad Hamim Sadewa, M. Robikhul Ikhsan, Yunilistiaingsih Yunilistiaingsih
Publikováno v:
Jurnal Manajemen dan Pelayanan Farmasi, Vol 6, Iss 4, Pp 261-269 (2016)
Metformin sebagai obat antidiabetik oral terpilih pada terapi diabetes melitus tipe 2 (DMT2) menunjukkan ketidaktercapaian target glikemik pada 35 – 40% pasien. Penelitian ini bertujuan menganalisis faktor pasien yang berpengaruh terhadap respon gl
Externí odkaz:
https://doaj.org/article/cbbdc4a13db54b649fb51ad5a12ce817